Download Equal Opportunities

BARTS AND THE LONDON NHS TRUST
Recruitment Material
For the post of
Consultant in Haemato-oncology
Part 1: Job Description
Part 2: The Trust, the Cancer Clinical Academic Unit
and the Haematological Oncology Service
Person Specification
BARTS AND THE LONDON NHS TRUST
CONSULTANT IN HAEMATOLOGICAL ONCOLOGY
JOB DESCRIPTION
SUMMARY:
The advertised post is for a full-time (10 PAs) Consultant in Haemato-oncology within
the Cancer Clinical Academic Unit at Barts and the London NHS Trust. This is a
replacement post and will be based at St Bartholomew’s Hospital.
The successful candidate will work with the Haemato-oncology Team in the provision of
services to patients with haematological malignancies. BLT is a provider for the
extended network for care of patients with haematological malignancies and is the only
level III/IV facility within the North East London Cancer Network. The successful
candidate would be expected to work with the existing team in providing in-patient and
out-patient management for patients with haematological malignancies, including stem
cell transplantation, and to participate in the associated teaching programmes. He/she
will also be expected to participate in professional medical responsibilities and training
of the junior staff.
The Haemato-oncology service is a component of the Cancer Clinical Academic Unit at
BLT and is closely allied to the Centre for Experimental Cancer Medicine in the Institute
of Cancer at Barts & The London School of Medicine & Dentistry. The successful
candidate will be encouraged to undertake research with colleagues in the Institute of
Cancer where there are significant opportunities for collaborative work. The Haematooncology service naturally has close links with the Medical Oncology and Clinical
Oncology services, as well as with the Clinical Haematology service, although the latter
comes under the Pathology Clinical Academic Unit, which is in a different division.
The successful candidate will need to demonstrate professional excellence and the
ability to deliver effective care. He/she will need to agree a job plan with the Clinical
Academic Unit Director and review this on an annual basis in the light of service
development and changes in activity levels.
The successful candidate will be required to adhere to the Trust’s policy on maintaining
medical excellence and to be committed to maintaining their standard of performance
by keeping their knowledge and skills up to date.
2
BARTS AND THE LONDON NHS TRUST
CONSULTANT IN HAEMATOLOGICAL ONCOLOGY
JOB DESCRIPTION
General duties of the post

To contribute to the provision of a comprehensive, efficient and high quality
evidence-based Haemato-oncology service, with continuing responsibility for the
care of patients in his/her charge, including all administrative duties associated
with patient care.

Leadership, development and organisation of the services in his/her charge in
line with Trust / Divisional business plans. Full participation in the management
of the Cancer Clinical Academic Unit (CAU) and the Haemato-oncology service.`
Liaison and communication with the Clinical Lead in Haemato-oncology , the
Clinical Academic Unit Director, the General Manager and with the Director and
Head of Operations of the Regional Services Division.

To develop his/her own interests and specialities within haemato-oncology,
including active participation in research programmes.

To participate in the undergraduate and postgraduate teaching programmes

To be responsible for continuing professional development

To maintain and promote team and multidisciplinary work.

To participate fully in the management of the Haemato-oncology Service and the
Cancer CAU and to liaise closely with the General Manager, the Clinical Lead
and the Director of the CAU

To participate fully in the preparation for and representation at peer review site
visits.

Corporate and individual responsibility for the professional management of
doctors in training

To engage fully in the annual job planning and appraisal cycle and to contribute
to the appraisal of doctors in training.
3
Specific duties of the post at Barts and the London Hospitals NHS Trust

To contribute to the provision of comprehensive, efficient and high quality care
throughout the treatment and management pathway of patients with
haematological malignancies.

To provide, with colleagues, specialist advice to patients and services for the
diagnosis and treatment of referred illness.

To provide, with colleagues, a referral service for inpatients under the care of
other clinical departments in the Trust, who are diagnosed with or develop
haematological malignancy-related complications during their inpatient stay.

To participate in the Consultant on-call rota (1:4) for which an appropriate on-call
supplement rate (Band B 3%) will be applied.

To provide evidence-based care for all inpatients and out-patients and to accept
personal responsibility for the total clinical care of the patients referred to
him/her.

To have regard at all times to the clinical and quality standards set out in the
NHS Cancer Plan, the Improving Outcomes reports and National Institute for
Clinical Excellence (NICE) guidance reports.

To participate in the supervision, training and professional development of the
junior medical staff working in the department.

To attend the weekly MDT case-review meeting.

To liaise effectively and on a timely basis with General Practitioners, community
services, and all healthcare agencies.

To provide, with colleagues, a referral service for inpatients under the care of
other clinical departments in the Trust, who are diagnosed with or develop
haematological malignancy during their inpatient stay.

To collaborate positively with colleagues to provide effective clinical leadership
for all the staff in the service.

To develop Risk Strategy Management in Haemato-oncology.

Infection control is a very important aspect of every employee’s role in the Trust
and it is expected that all policies and procedures for infection control would be
adhered to, including the adequate decontamination of hands before every
patient contact
4
On-call commitment
To participate with the existing team to provide cover for patients under the care of
Haemato-oncology, supervising the on-call SpR.
Accountability
The appointee will have full professional independence on medical matters but will be
managerially accountable to the Trust and the Chief Executive, through his/her CAU
Director.
Clinical Governance
The appointee is expected to participate in the Trust’s clinical effectiveness activities,
and to encourage and foster improvements in the quality and standards of clinical
services. The appointee will assist with the safeguarding of high standards of care by
participating in the creation of an environment in which excellence in clinical care will
flourish.
Continuing Professional Development and Continuing Medical Education
The appointee is expected to take responsibility for their own continuing professional
development (CPD) and take part in continuing medical education activities (CME), in
line with the requirements of the Royal College of Pathology and/or Physicians
guidelines to maintain standards of performance and in consultation with the CAU
Director
The appointee will be expected to be committed to the concept of lifelong learning and
produce and maintain a personal development plan in agreement with their CAU
Director
Study leave is available as provided for under the Terms and Conditions of Service for
Consultants (England) 2003 and subject to the approval of the CAU Director / General
Manager. At BLT the recommended standard for Consultants is a maximum of 30 days
in total in any period of 3 years within the United Kingdom, or 10 days per year within
the UK. This includes both professional and study leave. The Postgraduate Medical &
Dental Education Centre approves requests for study leave expenses. There is no set
allocation, but all course and meeting fees within the recommended standard for study
leave will be met (assistance is not generally provided with travel or accommodation
expenses).
Appraisal and Development
All consultants must undergo annual appraisal. This is conducted by an appraiser (or
appraisers) and is expected to provide key information with regard to continuing
5
professional development and in due course validation on a 5 yearly basis. Appraisal is
based on GMC guidelines and incorporates all clinical governance responsibilities of
the post.
Teaching and Training
The Trust is committed to sustaining and advancing the provision of medical, dental,
nursing and other professional education and to the delivery of high quality
postgraduate and undergraduate training.
The appointee will be expected to participate fully in the education of postgraduate
doctors within the Haemato-oncology Service and the Cancer CAU and, where
appropriate, across the Trust. This will involve regular teaching commitments agreed
with the CAU Director, and will be supervised by the Unit Training Director.
The appointee will also assist with the teaching of medical students attached to the
department, and with teaching non-medical personnel as appropriate.
Teaching within the department includes regular presentations, and informal practical
and theoretical training sessions.
Research and Development
The appointee will be expected to participate actively in clinical and laboratory based
research programmes and initiatives, in co-operation with the Institute of Cancer, under
the guidance of the Research and Development department and within the guidelines
of Trust policies. The appointee will be encouraged to initiate his/her own research
projects. The appointee will be expected to maximise recruitment of patients to
National Cancer Research Network-accredited trials.
Equal Opportunities
The appointee must at all times carry out responsibilities and duties with due regard to
the Trust’s Equal Opportunities Policy.
Health and Safety
The appointee is expected to undertake the appropriate management responsibilities,
and be aware of individual responsibilities in accordance with the Trust’s Health and
Safety policy and report as necessary, any untoward accident, incident or potentially
hazardous environment. The appointee will promote and implement the Health and
Safety Policy. The Trust operates a no smoking policy.
Infection Prevention and Control Roles
Infection Prevention and Control Roles and Responsibilities
6

To adhere to Trust policy and infection control principles and standards to minimise patient risk
and ensure high quality patient care.

Undertake appropriate training and practice to ensure you (and your teams) have the right skills
and are competent.

Are responsible for keeping the environment clutter free, clean and raising issues of concern in
the interest of staff and patient safety.

Ensure high cleaning standards to prevent infection and increase patient's confidence

Work together and with others to design the BLT IPC Service in line with national guidance

With others, support and develop good IPC practices consistent with national guidance and the
Trust's Pathfinder Strategy

Advise and support the Director of Infection Control and Prevention (DIPC), Deputy DIPC and
infection control team in achieving their objectives and fulfilling their responsibilities

Advise and support Divisional and CAU Infection Control leads
Salary and Conditions of Service
This appointment is subject to the Terms and Conditions of Service for Consultants
(England) 2003, to the General Whitley Council Conditions of Service and also to the
NHS Pension Scheme regulations. The illustrative job plan / timetable set out below are
in line with the Terms and Conditions of Service for Consultants (England) 2003.
The appointment is on a full time basis (i.e. an average of 10 programmed activities per
week). The present salary scale is £73,403 - £98,962 for 10 programmed activities.
Applicants must have completed specialist training in Haematology or Medical
Oncology and be on the Specialist Register before they take up this appointment.
The Trust requires the appointee to have and to maintain full registration with the
General Medical Council/Dental Council. Medical and dental staff are advised to
continue membership of a medical defence organisation.
The successful candidate will also receive a London Weighting allowance of £2,162 per
annum (London Zone).
Due to the nature of the work in this post, it is exempt from the provision of section 4 (2)
of the Rehabilitation of Offenders Act 1974, by virtue of the Rehabilitation of Offenders
Act 1974 (Exemption Order 1975).
Applicants are therefore not entitled to withhold information about convictions, including
those which, for other purposes are “spent”, under the provisions of the Act, and are
required to disclose convictions including those pending, to the Trust. Failure to
disclose such information may result in dismissal or disciplinary action.
The successful candidate will normally be required to live within 10 miles or 30 minutes
travelling time from the Trust.
7
Illustrative job plan and proposed timetable
This job plan is illustrative only and is in line with the Consultant Contract (England)
2003. It is subject to negotiation with the successful candidate and will be reviewed
annually by the CAU Director and the appointee. If there is a disagreement over the
appraisal, in the first instance the appraisee can approach a third party (a senior
member of staff) to act as a mediator. If the appraisee is still unhappy with the outcome,
the matter will be addressed through the Trust’s Grievance Policy & Procedure.
The table shows timetable commitments (currently 10 PAs) apportioned to direct clinical
care (DCC – 7.50 PAs) and supporting professional activity (SPA - 2.50 PAs).
Sessional commitments may be revised in the future by mutual agreement as the
needs of the service and the work patterns with oncology colleagues change.
8
Day
Monday
Tuesday
AM
PM
09.00 – 13.00
14.00 – 17.00
Clinical Research (1.25PA x SPA)
Clinical Research & Teaching
(0.75 PA x SPA)
08.30 – 11.00
14.00-16.00 (0.50 x DCC)
MDM (0.60PA x DCC)
Ward round/Day Unit
11.00-14.00 (0.75PA x DCC)
[for 6 months of the year each]
Ward round/Day Unit + clinical admin.
16.00 – 17.00 (0.25PA x SPA)
[for 6 months of the year each]
Wednesday
09.00 – 14.00
14.00 – 16.00
Outpatient Clinic + clinical admin. (1.25PA x
DCC)
Clinic-related admin. (0.50PA x
DCC)
16.00-17.00 (0.25PA x SPA)
Departmental Seminar (CME related
activity)
Thursday
09.00 – 14.00
14.00-15.00
Outpatient Clinic + clinical admin. (1.25PA x
DCC)
BMT meeting (0.25PA x DCC)
15.00-16.00
HLA typing meeting (0.25PA x
DCC)
16.00-17.00
Consultant meeting (0.25 PA x DCC)
Friday
09.00 – 14.00
14.00 – 16.30
Ward round/Day Unit + clinical admin. (1.25PA
x DCC)
Ward work and clinic-related admin.
(0.65 PA x DCC)
[for six months of the year each]
9
Office accommodation and secretarial support
The post-holder will have office accommodation in the Department of Haematooncology at Barts with a computer terminal for access to the Trust Electronic Patient
Record viewer.
Full time secretarial support is provided.
Hepatitis B and HIV/AIDS policy
Prior to employment the Trust will require you to undertake a medical examination
which will include Hepatitis B screening. The BMA code of conduct in case of doctors
who have HIV infection / AIDS should be followed. In such cases the Trust expects all
doctors to make disclosure to the Occupational Health Physicians whether they will be
undertaking invasive procedures or not.
Other aspects of the post / additional Information
This job description is an outline only. It is not exhaustive and may be altered from time
to time in accordance with the needs of the service, following negotiation with the
appointee. The appointee will be required to be co-operative and flexible in accordance
with the needs of the service.
In addition to their commitment to on-going patient care and the supporting professional
activities outlined on the preceding pages, all consultants at this Trust have a
continuing responsibility for the smooth functioning of their department / CAU and the
efficient management of its resources. This includes the provision of adequate cover
for colleagues on leave by mutual agreement.
Further information from:
Prospective candidates are encouraged to visit the Department of Haemato-oncology at
Barts, which may be arranged by contacting one of the following:
Dr Jamie Cavenagh, Clinical Lead in Haemato-Oncology
PA Reba Begum, 020 7601 8202
[email protected]
Professor John Gribben, Director of Bone Marrow Transplantation and Centre for
Experimental Cancer Medicine
PA Lynn Haddon, 020 7882 3804
[email protected]
Professor Nick Lemoine, Director of the Cancer CAU
PA Blanca Rybnickova, 020 7882 3503
[email protected]
10
BARTS AND THE LONDON NHS TRUST
CONSULTANT IN HAEMATOLOGICAL ONCOLOGY
Part 2: The Trust, the Cancer CAU and the
Haematological Oncology Service
General Information
The post holder will be expected to work closely with the Clinical Lead and the General
Manager in the management and administration of resources and to be active in
promoting changes which improve the delivery of service to patients.
Barts and the London NHS Trust
Barts and The London is one of Britain’s top teaching hospital trusts. Our mission is
literally to bring excellence to life – to give patients the best possible care so that they
can live better, fuller, longer lives.
Every year we care for over 500,000 people from the City, East London and beyond –
communities with a rich ethnic, religious and cultural diversity; from the affluent finance
and business centres of the City and Docklands, to the vibrant Bangladeshi community
in and around London’s Brick Lane.
The Trust is made up of the following leading teaching hospitals:

St Bartholomew’s Hospital (Barts) in the City of London

The Royal London Hospital in Whitechapel

The London Chest Hospital in Bethnal Green.
Barts and The London is organised into three divisions (Acute and Family Services;
Regional Services; Clinical and Diagnostic Services) under the leadership of the Chief
Executive.
Each Division is headed by a Divisional Director (Dr Celia Skinner in the case of
Regional Services) supported by a Divisional Head of Operations (Ms Julie Lamb for
Regional Services) and a Divisional Senior Nurse.
The Divisions comprise a varying number of Clinical Academic Units. The Cancer
Clinical Academic Unit lies in the Regional Services Division.
The Divisional Directors, supported by Operational Managers and CAU Directors, are
responsible for the day-to-day management and the running of the Trust's services,
while the Trust Board (comprising full-time executive directors and part-time nonexecutive directors) is accountable for setting the strategic direction of the Trust,
monitoring performance against objectives, ensuring high standards of corporate
governance and helping to promote links between the Trust and the local community.
11
The New Hospitals Development
Construction work is at an advanced stage to build Britain’s biggest new hospital on the
Royal London Hospital site in Whitechapel and to redevelop St Bartholomew’s as a
Cancer and Cardiac Centre of Excellence. The £1 billion private finance initiative
development is being carried out by the Skanska Innisfree John Laing consortium. The
entire redevelopment of both hospitals is expected to be completed in 2015. The new
Cancer Centre at Barts is due to open in 2010 and most new facilities at The Royal
London should be operational early in 2012.
Barts and the London Cancer Centre and the Institute of Cancer
Barts and The London Cancer Centre (www.bartsandthelondon.nhs.uk/cancercentre) is
based at Barts Hospital in the City of London. The centre is a major tertiary referral
centre for all forms of malignant disease in adults, providing cancer services to a
population of more than one and a half million people in East London and the City. Our
new hospitals programme will create a purpose-built Cancer and Cardiac Centre of
Excellence at Barts, providing facilities to improve the high standard of clinical care that
patients already receive.
In conjunction with the Institute of Cancer at Barts and The London, Queen Mary’s
School of Medicine and Dentistry (www.cancer.qmul.ac.uk) our mission is to establish a
major international centre of excellence in both cancer research and clinical cancer
care on the West Smithfield site at Barts Hospital and in Charterhouse Square.
Our clinical and research teams were awarded Experimental Cancer Medicine Centre
(ECMC) status by the Department of Health and Cancer Research UK and our
Experimental Cancer Unit was recently opened at the Barts site.
We are the specialist regional centre for cancer treatment in North East London and
belong to the North East London Cancer Network together with Homerton, Newham,
Whipps Cross, King George Ilford, and Queens Hospitals.
All cancer treatment in BLT is administered at Barts. Clinical Haematology is split
across both the St Bartholomew’s and Royal London sites.
Inpatient and day-case facilities
All Cancer Services facilities are located on the St Bartholomew’s site.
Patients with haematological malignancies are cared for on the Bodley Scott Unit which
comprises of 35 beds. The Bodley-Scott Unit consists of a purpose built 14 bedded
HEPA filtered bone marrow transplant unit, the 21 bed Bodley-Scott 2 Ward and the
haemato-oncology day unit (Bodley-Scott 3). The appointee will have full admitting
rights to the wards. The apheresis service is in a designated area within the day unit.
The day unit also has basic laboratory facilities to allow clinical trial samples to be
processed.
12
In addition to the Bodley Scott Unit, Cancer Services also includes 23 clinical oncology
beds on Rahere Ward and 23 solid tumour medical oncology beds on Gordon Hamilton
Fairley Ward. The Paget Day Unit is primarily a chemotherapy day unit for clinical and
medical oncology patients. There is also a 14 bed Patient Hostel for patients on the
Barts site.
The Cancer CAU has implemented a fully integrated clinical information / chemotherapy
prescribing system.
There are no dedicated Palliative Care beds. Patients are jointly managed with the
team led by Drs Clare Phillips, Teresa Tate and David Feuer (Clinical Lead), Consultant
Physicians in Palliative Care.
Full pathological (haematology, biochemistry and transfusion) and imaging facilities
(including both CT, MRI and CT-PET) are available at Barts. As previously mentioned,
Pathology services are part of the Pathology Cancer Academic Unit and the Haematooncology Service has no responsibilities for managing the routine pathology
laboratories. The post-holder will have access to microscopes within the haematooncology laboratory facilities, including a multi-headed microscope. Bone marrow and
blood film reporting is performed by Dr Mike Jenner.
Outpatient clinics
There are 3 outpatient clinics held by the service every week which are held either in
the Main Outpatient Department or in the West Wing Outpatient Clinic both at St
Bartholomew’s Hospital.
Haematolo-oncology Centre
The service provides specialised care for patients with haematological malignancies
treated within The Cancer Centre at Barts and The London. The service is responsible
for the management of haematological malignancy for City and Hackney and Tower
Hamlets PCT and as the tertiary referral centre for the North East London Cancer
Network but also for most of Essex including Southend, Basildon, Colchester and
Chelmsford Hospitals, thereby providing supra-regional specialized care for patients
with acute and chronic leukaemia, lymphoma, multiple myeloma and related illnesses.
The centre is the designated level III/IV facility for the Network and beyond. Specialized
services include bone marrow transplant (BMT). The service has been designated by
the Trust as leading edge.
All patients with haematological malignancies are managed by the Haematooncologists at St Bartholomew’s Hospital. Those patients who are diagnosed by the
Clinical Haematology service are referred for further management at Barts. Similarly,
newly presenting patients admitted under the medical teams at the Royal London are
transferred as soon as possible for appropriate care at Barts. The Clinical Haematology
service deals primarily with all non-malignant haematology, but obviously manages
haemato-oncology patients who are receiving treatment for other reasons at the Royal
London site.
13
Inpatient and day case facilities
In 2008/9, there were 537 documented new patients seen and 7415 out-patient visits.
There were 1845 attendances in the Bodley Scott Day Unit where day case
chemotherapy is delivered to patients. There were more than 100 direct admissions of
new patients with acute leukaemia to the in-patient service and 1180 admissions to the
wards. BMT activity is increasing, with 105 procedures performed in 2008/9, including
46 allogeneic transplants. The submission for JACIE accreditation of BMT services is
planned for late 2009.
There has been a shift in activity to an increased number of allogeneic BMT, with the
majority of these procedures now performed with reduced intensity conditioning
delivered as an out-patient, with these patients seen weekly in the Consultant led BMT
clinic. The SLA with the Pan Thames BMT Consortium was costed at £3.6M for 2008/9.
In keeping with DoH directives, increasing work-load is being performed in the outpatient setting, thereby increasing the Consultant workload.
Clinical Trials
A major component of the work is clinical trial activity. Entry for haematological
malignancies at Barts accounts for more than 50% of the NCRN sponsored randomized
clinical trials activity of the network. Barts has been one of the biggest recruiters to
NCRI trials (eg 4th largest UK recruiting centre to AML-15). The Consultant staff play a
major role as lead investigators on NCRN study groups in haematological malignancies.
There are currently over 30 clinical trials recruiting patients with haematological
malignancies.
Multidisciplinary meetings
As required, all new patients and all new events are reviewed in the weekly MDM, for
patients seen at Barts and The London, Newham and Homerton Hospitals, and the
MDM has recently been expanded to also cover all patients seen at Whipps Cross. It is
recognised that this requires expansion of the MDM to review this increased activity, as
well as to comply with the recommendation of the Haematology Peer Review for review
of patients with different subtypes of malignancies. Together these measures have
required lengthening of the MDM to twice its previous level of activity, increasing the
workload for each consultant as key members of the MDM with required attendance.
The weekly MDM meeting is held in the Williamson Library.
Outpatient clinics
Out-patient clinics are held in the Main Outpatient Department at Barts and in the
purposely designed and newly opened £13.5 million Breast Care Centre on
Wednesday.
Staffing Summary/
Clinical Activity
There are 15 Consultant sessions weekly at the Haemato-oncology clinics which are
held each week on Monday, Wednesday and Thursday. The service operates with two
teams to cover specialised in-patient service and each team has a Consultant led ward
round twice weekly, so that there are 4 Consultant ward rounds each week. There is a
14
weekly review of BMT patients attended by all Consultants, and a bi-weekly Tissue
Typing meeting.
The current Consultant workload of the Haematological Oncology service is provided by
the following staff:
Dr Samir Agrawal, Senior Lecturer and Honorary Consultant in Haematology
Dr Rebecca Auer, Senior Lecturer and Honorary Consultant in Haematology
Dr Jamie Cavenagh, Consultant and Honoraray Reader in Haematology
Professor John Gribben, Professor of Experimental Cancer Medicine
Dr Michael Jenner, Consultant Haematologist
Professor T Andrew Lister, Professor of Medical Oncology
Dr Silvia Montoto, Senior Lecturer and Honorary Consultant in Medical Oncology
Dr Heather Oakervee, Senior Lecturer and Honorary Consultant in Haematology
Dr Manoj Raghavan, Senior Lecturer and Honorary Consultant in Haematology
Professor Ama Rohatiner, Professor of Haemato-Oncology
Dr David Taussig, Senior Lecturer and Honorary Consultant in Haematology
Radiologists
Consultant Radiologist, Lead, Dr Sarah Vinnicombe
Consultant Radiologist, Dr Ian Goddard
Haemato- Pathologists
Haematology Pathology Lead, Dr Maria Calaminici
Consultant Pathologist, Dr Hasan Rivzi
Clinical Oncologists
Consultant Clinical Oncologist, Dr Melanie Powell
Clinical Nurse Specialists
Leukaemia Clinical Nurse Specialist, Elaine Stewart
Myeloma Clinical Nurse Specialist, Emma Masters
Lymphoma Clinical Nurse Specialist, Louise Smith
Four BMT Clinical Nurse Specialists:
Sonia Rissman, Filipo Oliviero, Samantha Miles & Marissa Farrell
Junior Doctors
2 Foundation Year 1 Trainees
1 Foundation Year 2 Trainee
4 Senior House Officers
2 Clinical Fellows (SHO Grade)
4 SpRs in Haematology
15
2 SpRs in Medical Oncology
Research
The Cancer Services Directorate has research laboratory facilities in Little Britain and
on the Medical College site off Charterhouse Square. The Haemato-oncology research
is funded through Cancer Research UK and the Leukaemia Research Fund, and
research interests not only include clinical studies in the management of leukaemia,
lymphoma and myeloma but also parallel laboratory work including the “molecular”
follow-up of patients on and post-treatment. The research laboratories have excellent
facilities for cytogenetic analysis and molecular biology.
CME and postgraduate education
Full library facilities exist on the Barts, Royal London and Charterhouse sites, including
Internet and Medline access. The majority of the national and international oncology
journals can be found within the Directorate departmental collections. Across the
Directorate there is an extensive timetable of multidisciplinary meetings and Research
Seminars. The Medical College holds weekly Grand Rounds on both sites
16
BARTS AND THE LONDON NHS TRUST
CONSULTANT IN HAEMATOLOGY ONCOLOGY
PERSON SPECIFICATION
Qualifications
Knowledge
Essential
MB BS, or equivalent
MRCP , or equivalent
FRCPath or equivalent
(if CCST in
Haematology)
CCST in haematology
or medical oncology (or
within 3 months of date
of interview)
Broad based knowledge
of and understanding of
Haematological
Oncology.
Training Expected
Higher Specialist
Training in Haematology
Experience in teaching /
training undergraduates
and postgraduates
Management/Audit
Experience
Academic
Achievements
Experience of clinical
audit
Experience of research
Research Publications
Personal Skills
Personal Qualities
Publications in indexed
journals
Good presentational
and verbal skills
Ability to motivate and
develop medical
trainees
Self motivated
Able to work as part of a
team
Ability to work under
pressure
Reliable work record
17
Desirable
Higher degree,
e.g. MD/PhD
Specialist experience in
management of lymphoma
Formal management training
(e.g. course)
PhD/ MD Thesis
Computer literacy/ IT skills
appropriate to a clinical
service using computerised
record systems and
electronic prescribing system
(VARIS)